Ih-Jen Su

Title: Innovations of Ih-Jen Su in Alzheimer's Disease Treatment

Introduction

Ih-Jen Su is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease. With a total of 4 patents to his name, his work focuses on innovative therapeutic methods that aim to improve the quality of life for those affected by this debilitating condition.

Latest Patents

One of Ih-Jen Su's latest patents is a combined therapy for treating Alzheimer's disease. This patent discloses a therapeutic method that provides a means for preventing, ameliorating, and/or treating Alzheimer's disease in individuals in need of such treatment. The method involves administering a pharmaceutical combination that includes an effective amount of curcumin analog, TML-6, and an effective amount of an anti-A beta (Aβ) antibody. Another significant patent involves the uses of a curcumin derivative, which outlines a method for preventing and/or treating Alzheimer's disease. This method also includes administering an effective amount of TML-6, along with a pharmaceutically acceptable carrier or excipient.

Career Highlights

Throughout his career, Ih-Jen Su has worked with esteemed organizations such as the National Health Research Institutes and Merry Life Biomedical Company, Ltd. His experience in these institutions has allowed him to develop and refine his innovative approaches to treating Alzheimer's disease.

Collaborations

Ih-Jen Su has collaborated with notable colleagues, including Wenya Huang and Feng-Shiun Shie. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Ih-Jen Su's work in the field of Alzheimer's disease treatment showcases his dedication to innovation and improving patient outcomes. His patents reflect a commitment to finding effective therapies that can make a difference in the lives of those affected by this challenging condition.